{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:11:41Z","timestamp":1761581501430},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/pcan.2016.64","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T11:21:46Z","timestamp":1483442506000},"page":"193-196","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease"],"prefix":"10.1038","volume":"20","author":[{"given":"J J","family":"Tosoian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Gergis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Narang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"McNutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A E","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D Y","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T L","family":"DeWeese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P T","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P C","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"key":"BFpcan201664_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A . Cancer statistics. CA Cancer J Clin 2015; 65: 5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"BFpcan201664_CR2","first-page":"1","volume":"6736","author":"FH Schr\u00f6der","year":"2014","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ, Tammela TLJ, Zappa M, Nelen V et al. Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 6736: 1\u20139.","journal-title":"Lancet"},{"key":"BFpcan201664_CR3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R et al. Systematic review of complications of prostate biopsy. Eur Urol 2013; 64: 876\u2013892.","journal-title":"Eur Urol"},{"key":"BFpcan201664_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.7326\/0003-4819-149-3-200808050-00008","volume":"149","author":"U.S. Preventive Services Task Force","year":"2008","unstructured":"U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 185\u2013191.","journal-title":"Ann Intern Med"},{"key":"BFpcan201664_CR5","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/cncr.26392","volume":"118","author":"E Scosyrev","year":"2012","unstructured":"Scosyrev E, Messing EM, Mohile S, Golijanin D, Wu G . Prostate cancer in the elderly. Cancer 2012; 118: 3062\u20133070.","journal-title":"Cancer"},{"key":"BFpcan201664_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1200\/JCO.2014.57.2743","volume":"33","author":"JE Bekelman","year":"2015","unstructured":"Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D et al. Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer. J Clin Oncol 2015; 33: 716\u2013722.","journal-title":"J Clin Oncol"},{"key":"BFpcan201664_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1200\/JCO.2010.30.2075","volume":"29","author":"SK Bechis","year":"2011","unstructured":"Bechis SK, Carroll PR, Cooperberg MR . Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol 2011; 29: 235\u2013241.","journal-title":"J Clin Oncol"},{"key":"BFpcan201664_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1464-410X.2007.07410.x","volume":"101","author":"L Richstone","year":"2008","unstructured":"Richstone L, Bianco FJ, Shah HH, Kattan MW, Eastham JA, Scardino PT et al. Radical prostatectomy in men aged \u2a7e70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram. BJU Int 2008; 101: 541\u2013546.","journal-title":"BJU Int"},{"key":"BFpcan201664_CR9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.juro.2008.01.044","volume":"179","author":"BR Konety","year":"2008","unstructured":"Konety BR, Cowan JE, Carroll PR . Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE. J Urol 2008; 179: 1797\u20131803.","journal-title":"J Urol"},{"key":"BFpcan201664_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1532-5415.2008.02091.x","volume":"57","author":"M Ketchandji","year":"2009","unstructured":"Ketchandji M, Kuo Y-F, Shahinian VB, Goodwin JS . Cause of death in older men after the diagnosis of prostate cancer. J Am Geriatr Soc 2009; 57: 24\u201330.","journal-title":"J Am Geriatr Soc"},{"key":"BFpcan201664_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1470-2045(02)00730-1","volume":"3","author":"L Repetto","year":"2002","unstructured":"Repetto L, Balducci L, Yancik R, Ries L, Vecchia C, La, Lucchini F et al. A case for geriatric oncology. Lancet Oncol 2002; 3: 289\u2013297.","journal-title":"Lancet Oncol"},{"key":"BFpcan201664_CR12","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.juro.2015.06.075","volume":"194","author":"DA Barocas","year":"2015","unstructured":"Barocas DA, Mallin K, Graves AJ, Penson DF, Palis B, Winchester DP et al. The Effect of the USPSTF Grade D recommendation against screening for prostate cancer on incident prostate cancer diagnoses in the united states. J Urol 2015; 194: 1587\u20131593.","journal-title":"J Urol"},{"key":"BFpcan201664_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/cncr.29691","volume":"122","author":"BA Mahal","year":"2016","unstructured":"Mahal BA, Aizer AA, Efstathiou JA, Nguyen PL . Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer. Cancer 2016; 122: 78\u201383.","journal-title":"Cancer"},{"key":"BFpcan201664_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1309\/AJCPJK9V9LUMUETV","volume":"137","author":"RT Vollmer","year":"2012","unstructured":"Vollmer RT . The dynamics of death in prostate cancer. Am J Clin Pathol 2012; 137: 957\u2013962.","journal-title":"Am J Clin Pathol"},{"key":"BFpcan201664_CR15","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","volume":"324","author":"WJ Catalona","year":"1991","unstructured":"Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJJ et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156\u20131161.","journal-title":"N Engl J Med"},{"key":"BFpcan201664_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","volume":"14","author":"JL Mohler","year":"2016","unstructured":"Mohler JL, Armstrong AJ, Bahnson RR, D\u2019Amico AV, Davis BJ, Eastham JA et al. Prostate cancer, Version 1. 2016 J Natl Compr Canc Netw 2016; 14: 19\u201330.","journal-title":"J Natl Compr Canc Netw"},{"key":"BFpcan201664_CR17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA . The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 2016; 40: 244\u2013252.","journal-title":"Am J Surg Pathol"},{"key":"BFpcan201664_CR18","doi-asserted-by":"publisher","first-page":"8146","DOI":"10.1200\/JCO.2005.02.9751","volume":"23","author":"MR Cooperberg","year":"2005","unstructured":"Cooperberg MR, Moul JW, Carroll PR . The changing face of prostate cancer. J Clin Oncol 2005; 23: 8146\u20138151.","journal-title":"J Clin Oncol"},{"key":"BFpcan201664_CR19","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.289.11.1414","volume":"289","author":"BE Sirovich","year":"2003","unstructured":"Sirovich BE, Schwartz LM, Woloshin S . Screening men for prostate and colorectal cancer in the United States. JAMA 2003; 289: 1414.","journal-title":"JAMA"},{"key":"BFpcan201664_CR20","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1200\/JCO.2010.31.9004","volume":"29","author":"MW Drazer","year":"2011","unstructured":"Drazer MW, Huo D, Schonberg MA, Razmaria A, Eggener SE . Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol 2011; 29: 1736\u20131743.","journal-title":"J Clin Oncol"},{"key":"BFpcan201664_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s11606-010-1468-9","volume":"25","author":"SB Zeliadt","year":"2010","unstructured":"Zeliadt SB, Hoffman RM, Etzioni R, Ginger VAT, Lin DW . What happens after an elevated PSA test: the experience of 13,591 veterans. J Gen Intern Med 2010; 25: 1205\u20131210.","journal-title":"J Gen Intern Med"},{"key":"BFpcan201664_CR22","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.urolonc.2012.04.005","volume":"31","author":"ZK Mohamed","year":"2013","unstructured":"Mohamed ZK, Dominguez-Escrig J, Vasdev N, Bharathan B, Greene D . The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level\u226415 ng\/ml and normal digital rectal examination: a 10-year prospective follow-up study of 427 consecutive patients. Urol Oncol 2013; 31: 1489\u20131496.","journal-title":"Urol Oncol"},{"key":"BFpcan201664_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1464-410X.2006.06603.x","volume":"99","author":"SRJ Bott","year":"2007","unstructured":"Bott SRJ, Foley CL, Bull MD, Reddy CCJ, Freeman A, Montgomery BSI et al. Are prostatic biopsies necessary in men aged > or =80 years? BJU Int 2007; 99: 335\u2013338.","journal-title":"BJU Int"},{"key":"BFpcan201664_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1311593","volume":"370","author":"A Bill-Axelson","year":"2014","unstructured":"Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014; 370: 932\u2013942.","journal-title":"N Engl J Med"},{"key":"BFpcan201664_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.urolonc.2009.12.022","volume":"28","author":"JT Wei","year":"2010","unstructured":"Wei JT . Limitations of a contemporary prostate biopsy: The blind march forward. Urol Oncol Semin Orig Investig 2010; 28: 546\u2013549.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"BFpcan201664_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N et al. Comparison of MR\/ultrasound fusion\u2013guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015; 313: 390.","journal-title":"JAMA"},{"key":"BFpcan201664_CR27","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.juro.2008.11.117","volume":"181","author":"EM Schaeffer","year":"2009","unstructured":"Schaeffer EM, Carter HB, Kettermann A, Loeb S, Ferrucci L, Landis P et al. Prostate specific antigen testing among the elderly-when to stop? J Urol 2009; 181: 1606\u20131614.","journal-title":"J Urol"},{"key":"BFpcan201664_CR28","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1200\/JCO.2015.62.5764","volume":"33","author":"JJ Tosoian","year":"2015","unstructured":"Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ et al. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. J Clin Oncol 2015; 33: 3379\u20133385.","journal-title":"J Clin Oncol"},{"key":"BFpcan201664_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico A V . Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969.","journal-title":"JAMA"},{"key":"BFpcan201664_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.6004\/jnccn.2014.0007","volume":"12","author":"G Rodrigues","year":"2014","unstructured":"Rodrigues G, Lukka H, Warde P, Brundage M, Souhami L, Crook J et al. The prostate cancer risk stratification project: database construction and risk stratification outcome analysis. J Natl Compr Canc Netw 2014; 12: 60\u201369.","journal-title":"J Natl Compr Canc Netw"},{"key":"BFpcan201664_CR31","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1002\/cncr.28932","volume":"120","author":"R Gulati","year":"2014","unstructured":"Gulati R, Tsodikov A, Etzioni R, Hunter-Merrill R a, Gore JL, Mariotto AB et al. Expected population impacts of discontinued prostate-specific antigen screening. Cancer 2014; 120: 3519\u20133526.","journal-title":"Cancer"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pcan201664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201664","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pcan.2016.64","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:11:45Z","timestamp":1648674705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pcan201664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFpcan201664"],"URL":"https:\/\/doi.org\/10.1038\/pcan.2016.64","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]},"assertion":[{"value":"29 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}